Health Professional Radio

Health Professional Radio - Podcast

Health EN ↓ 779 episodes

Health Professional radio gives you access to interesting and entertaining interviews, news updates, professional profiles, research updates on a broad range of topics related to health.

Author

Health Professional Radio

Category

Health

Latest episode

Jan 17, 2024

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Patient Living with Pompe Disease and Participant in the COMET Clinical Trial 03.09.2021

Alison Miles, a patient living with Pompe disease, a condition that develops when the body can't make a protein that breaks down a complex sugar, glycogen, shares her unique diagnosis journey, the importance of self-education and patient empowerment, and the company she started, due to her mobility issues, for functional socks with grips that were fashionable. She discusses her experience with Nex...

Numinus Wellness - Psychedelic Assisted Therapies 03.09.2021

Dr. Devon Christie, MD, is the Medical and Therapeutic Services Director with Numinus Wellness Inc., a Canadian-based company at the forefront of advancing safe, effective and innovative psychedelic-assisted therapies, and a clinical instructor with the UBC Department of Medicine, shares some insights about the therapy and why the U.S. should consider this type of therapy for those who medically q...

Jazz Pharmaceuticals - Nothing Small About It SCLC Online Program 03.09.2021

Abizer Gaslightwala, Vice President, Head of U.S. Hematology and Oncology at Jazz Pharmaceuticals, discusses the "Nothing Small About It" online program developed with leading cancer organizations focused exclusively on the psychosocial and emotional needs of the small cell lung cancer (SCLC) community. By creating the first and only digital hub focused exclusively on SCLC, Jazz and partners aim t...

New Treatment for Chronic Rhinosinusitis with Nasal Polyps 03.09.2021

Dr. Jared Silver, MD, PhD, Allergist Immunologist & Indication Lead for Mepolizumab, US Medical Affairs Respiratory at GSK discusses the recent FDA approval of NUCALA (mepolizumab) as an add-on maintenance treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in adult patients 18 years of age and older with inadequate response to nasal corticosteroids. He explains why incorporating a bio...

Paragonix Technologies, Inc. - A Study On Donor Lung Transport and Preservation 03.09.2021

Dr. Lisa Anderson, CEO, President and co-founder of Paragonix Technologies, Inc., a company delivering a new standard in organ preservation and transport, discusses a new research study called GUARDIAN-LUNG (Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs) to look at lung preservation and how the way the organ is preserved and transported impact the success of the...

Sanofi Genzyme - Humanitarian Aid Program to Treat Rare Diseases 03.09.2021

Shannon Resetich, Global Franchise Head, Rare Diseases at Sanofi Genzyme discusses the company's Humanitarian Aid Program started 30 years ago. The program is largely focused on patients with lysosomal storage disorder (LSDs) diseases who need enzyme replacement therapies. She talks about how this humanitarian program helps to ensure patients with LSDs have access to treatment no matter where they...

Reducing Opioid Treatment in the Surgical Setting 02.09.2021

Pain Awareness Month is September and Dr. Alan Rechter, MD, an orthopedic surgeon, from Orthopoedic Associates in Houston, TX, discusses the newest method of effectively managing postoperative pain without opiods. He will explain why this latest development is such an important step in helping patients who are undergoing a variety of procedures.

Alcon - TOTAL30® - Latest Monthly Replacement Contact Lens 02.09.2021

Carla Mack, Global Head of Professional Affairs at Alcon discusses the company's latest innovation, TOTAL30®, the first-and-only monthly replacement, water gradient contact lens that feels like nothing even at day 30. This lens offers a new solution to the 'say nothing' patients and helps to better retain more contact lens wearers.

Spinal Muscular Atrophy (SMA) Awareness - Patient Treated with Evrysdi 02.09.2021

August is Spinal Muscular Atrophy (SMA) Awareness Month, and this year (2021) also marks the first anniversary of the FDA approval of Evrysdi (risdiplan) to treat SMA in adults and children two months and older. Here to talk about how this treatment has improved patient’s lives is Eric Arnold, a 35 year old lawyer in West Virginia who is grateful for the new treatments available to SMA patients an...

Revive Therapeutics - Studying Bucillamine to Treat COVID 02.09.2021

​​Michael Frank, CEO and Chairman of Revive Therapeutics discusses the Phase 3 trial of Bucillamine, a well known prescribed anti-inflammatory drug in Japan and South Korea, as an oral at-home pill treatment option for mild-moderate to severe COVID-19.

Improving Health Communications About COVID-19 02.09.2021

Overview ​​Dr. Andy Lazris, MD, and Dr. Erik Rifkin, PhD, co-founders of the Center for Interpreting Health Benefits and Risk discuss their new book "Understanding COVID-19 Risks: An Image is Worth More Than 1,000 Words", (July 2021). They also talk about the Benefit-Risk Characterization Theatre (BRCT) which they developed and how they believe this can be an essential tool in clearing up a lot of...

Back To School RSV Considerations 02.09.2021

​​Jasmin Makar, MD, a pediatrician with Stanford Children's Health, discusses ways kids can stay safe as they go back to school, the importance of seasonal vaccines and year-round wellness checks.

Architecture For Senior Living 02.09.2021

Vincent Myers, President and co-founding member of DIGroup Architecture, an award winning design firm in New Brunswick, New Jersey discusses why senior living has become a "health care product" according to "Senior Housing News" in their 'Top Ten Trends for 2021' and where architectural design fits into this new dynamic.

Sleep Researcher On New Insomnia Treatment 02.09.2021

​​Margaret Moline, PhD, Executive Director, Neurology Business Group at Eisai discusses her work developing the first insomnia treatment to be approved by the FDA in the past five years. She talks about the importance of sleep, sleep hygiene and the increased prevalence of insomnia due to the COVID-19 pandemic.

Small Cell Lung Cancer (SCLC) Survivor 02.09.2021

​​Montessa Lee, a small cell lung cancer (SCLC) survivor and advocate since 2006, discusses her SCLC journey, how she navigated her diagnosis at 28 years old, and how her story of survival - told through the “Nothing Small About It” program - can inspire others.

Diabetes Research and its Relationship to Cancer 02.09.2021

Dr. Debbie Thurmond, Ph. D., Director of the City of Hope's Arthur Riggs Diabetes & Metabolism Research Institute discusses the institute's focus on the intersection of diabetes and cancer, helping to answer the reasons why diabetes is significantly associated with an increase in cancer and how the growing number of highly effective cancer therapies may cause insulin-dependent diabetes. She also t...

Know the Difference Between COVID-Delta Variant and Cold-Allergy Symptoms 24.08.2021

Allergist and immunologist Dr. Payel Gupta, professor at SUNY Downstate Medical Center and Mt. Sinai Medical Center, discusses differences between symptoms often seen with COVID-19 (including the latest Delta variant) compared to symptoms of a common cold and/or environmental allergies. Dr. Gupta outlines why it is critical to know the difference and at what point to consult a physician, in additi...

Respiratory Syncytial Virus (RSV) Has Been Spreading in Unprecedented Levels This Summer 24.08.2021

Dr. Michael Forbes, Pediatric & Adolescent Intensive Care Specialist and the Director of PICU Clinical Research & Outcomes Analysis at Akron Children’s Hospital​,​ discusses respiratory syncytial virus (RSV), a common, contagious virus that causes flu-like illness in infants and toddlers​,​ and the concern over the recent summer surge in cases. The CDC recently expressed particular concern that th...

S.H.I.N.E.® Protocol to Combat Long COVID or Post Viral Chronic Fatigue Syndrome 24.08.2021

Tammy Krotz, 57, shares her experience contracting COVID-19. After being technically virus-free her condition worsened into what is being called "long COVID" or post-viral chronic fatigue syndrome. She is joined by Dr. Jacob Teitelbaum whose S.H.I.N.E.® protocol she says literally saved her life. Tammy Krotz, 57, is a Special Ed teacher in Hiawatha, Iowa. She’s always been “high energy,” and would...

RYAH Group - Medical Plant and Nutraceutical Intake Industry 24.08.2021

Gregory Wagner, CEO of RYAH Group, a publicly listed big data and technology company focused on valuable predictive analysis in the global medical plant intake industry discusses the significance of data in the cannabis industry and why companies leading with data will be golden in the cannabis sector. While RYAH offers many different IoT products/devices such as smart inhalers, smart-pens and sma...

Cardiol Therapeutics, Inc. - CardiolRx™ Phase II & III Outcomes Study 24.08.2021

David Elsley, MBA, President and CEO of Cardiol Therapeutics, Inc., a clinical stage biotech, discusses the Company's research and clinical development of innovative anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). David talks about the Company's lead product, CardiolRx™ a pharmaceutically produced oral cannabidiol formulation that has entered a Phase II/III outcomes...

GSK Longstanding Legacy & Lasting Leadership in BENLYSTA Commercialization 24.08.2021

Sheri Mullen, Senior Vice President, Specialty Business Unit, US Pharma at GSK discusses BENLYSTA (belimumab), the first and only biologic approved for lupus and lupus nephritis in adults, and its decade-in-market milestone. She shares insights around GSK leadership in reducing progression of long-term organ damage with BENLYSTA's proven efficacy, investing in comprehensive lupus programs and clin...

4th Edition From Fatigued to Fantastic Provides New Strategies For Long Covid 24.08.2021

Returning guest, board-certified internist, Dr. Jacob Teitelbaum, MD, discusses the recently released (June 2021) 4th edition of his book "From Fatigued to Fantastic: A Clinically Proven Program to Regain Vibrant Health and Overcome Chronic Fatigue and Fibromyalgia" that now offers critical support for those with "long-hauler" syndrome following COVID-19 as well as new strategies for managing chro...

Contraception Choices & Unintended Pregnancies 24.08.2021

Dr. Edio Zampaglione, Head of Global Medical Affairs and Outcomes Research at Organon and an OBGYN, discusses unintended pregnancies, the importance of starting conversations about birth control options with college-bound students, and a new study published in "Pediatrics" that shows that conversations with adolescents about sexual and reproductive health, other than puberty, aren’t routinely taki...

New Study - More Than 50 Percent of Patients with Diabetes Fall Short on Protein Intake 18.08.2021

Sara Thomas, PhD, RD, registered dietician and research scientist at Abbott, discusses a new study from Abbott and The Ohio State University that was published in "Nutrients" that showed that adults with diabetes with low protein leads to physical limitations, lower overall diet quality, poorer nutrition density and more carbohydrates consumed. Sara Thomas , PhD, RD is a registered dietitian and a...

Listen to the Health Professional Radio - Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.